Institute of Medicinal Molecular Design, Inc.   Report issue

For profit Phase 2
Founded: Tokyo Japan (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2008
NCT00883584
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

imd-1041 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1